November 2024

The pharmaceutical industry is built on a foundation of high-risk, high-reward innovation. The traditional path of de novo drug discovery […]

For decades, the pharmaceutical world revolved around a predictable axis: the triad of North America, Europe, and Japan. These regions

Executive Summary The engagement of a Contract Development and Manufacturing Organization (CDMO) has fundamentally evolved from a tactical cost-saving measure

Executive Briefing: Pricing Is Not an Art, It’s an IP-Driven War Let’s be blunt. Setting the launch price for a

Introduction: More Than a Copy, A Scientific and Strategic Endeavor In the world of pharmaceuticals, the term “generic” has long

Introduction: The Unseen Engine of Modern Healthcare The generic drug industry operates at the center of a fundamental paradox. It

Executive Summary The generic pharmaceutical industry stands at a pivotal juncture, transitioning from a high-volume, cost-driven operational model to a

The pharmaceutical industry has long operated under the paradigm that achieving blockbuster status for a drug necessitates substantial US market

The tectonic plates of the global pharmaceutical industry are shifting. For decades, the epicenters of profit and innovation were firmly